Close Menu

NEW YORK — VolitionRx said today that it has received  $1.4 million in non-dilutive funding through a grant from the Wallonia region of Belgium where the company is headquartered.

Unlike a recent $700,000 grant from Wallonia, this latest award is non-repayable, VolitionRx said. To date, the region has given the company about $6 million in non-dilutive funding.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.